Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lorand

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
Experimental Eye Research|June 17, 1998
Novel inhibitors against the transglutaminase-catalysed crosslinking of lens proteinsL Lorand, A M Stern, P T Velasco
Seminars in Hematology|January 1, 1979
Enzymatic basis of membrane stiffening in human erythroyctesL Lorand, G E Siefring, L Lowe-Krentz
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Fibronectin as a carrier for the transglutaminase from human erythrocytesL Lorand, J E Dailey, P M Turner
Investigative Ophthalmology & Visual Science|July 1, 1987
Inhibition of beta-crystallin cross-linking in the Ca2+-treated lensL Lorand, S M Conrad, P T Velasco
Biochemistry|February 1, 1972
Enzymatic coupling of isoniazid to proteinsL Lorand, L K Campbell, B J Robertson
Experimental Eye Research|October 21, 1998
Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTPS N Murthy, P T Velasco, L Lorand
Biochemistry|January 29, 1991
Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIIIM C Naski, L Lorand, J A Shafer
Biophysical Chemistry|August 1, 1974
Viscoelastic properties of ligation-inhibited fibrin clotsL F Mockros, W W Roberts, L Lorand
Biochemistry|June 23, 1981
Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspectsR B Credo, C G Curtis, L Lorand
British Journal of Haematology|February 1, 1974
A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemiaR D Rosenberg, R W Colman, L Lorand
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
Experimental Eye Research|June 17, 1998
Novel inhibitors against the transglutaminase-catalysed crosslinking of lens proteinsL Lorand, A M Stern, P T Velasco
Seminars in Hematology|January 1, 1979
Enzymatic basis of membrane stiffening in human erythroyctesL Lorand, G E Siefring, L Lowe-Krentz
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Fibronectin as a carrier for the transglutaminase from human erythrocytesL Lorand, J E Dailey, P M Turner
Investigative Ophthalmology & Visual Science|July 1, 1987
Inhibition of beta-crystallin cross-linking in the Ca2+-treated lensL Lorand, S M Conrad, P T Velasco
Biochemistry|February 1, 1972
Enzymatic coupling of isoniazid to proteinsL Lorand, L K Campbell, B J Robertson
Experimental Eye Research|October 21, 1998
Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTPS N Murthy, P T Velasco, L Lorand
Biochemistry|January 29, 1991
Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIIIM C Naski, L Lorand, J A Shafer
Biophysical Chemistry|August 1, 1974
Viscoelastic properties of ligation-inhibited fibrin clotsL F Mockros, W W Roberts, L Lorand
Biochemistry|June 23, 1981
Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspectsR B Credo, C G Curtis, L Lorand
British Journal of Haematology|February 1, 1974
A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemiaR D Rosenberg, R W Colman, L Lorand
Pageof 14